drugset / Trial / NCT00175747
A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)
Phase 2/3
Completed
120 enrolled
University of British Columbia
National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
Studies in animals suggest that inhaled budesonide may prevent the occurrence of lung cancer. We conducted a clinical trial to determine the effects of inhaled budesonide in smokers who had precancerous lesions in the breathing tubes (i.e. bronchial dysplasia.
Timeline
- Start
- 2000-01
- Primary completion
- —
- Completion
- 2002-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 800 ug | Inhaled |